KR20170042376A - 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 - Google Patents

장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 Download PDF

Info

Publication number
KR20170042376A
KR20170042376A KR1020177009431A KR20177009431A KR20170042376A KR 20170042376 A KR20170042376 A KR 20170042376A KR 1020177009431 A KR1020177009431 A KR 1020177009431A KR 20177009431 A KR20177009431 A KR 20177009431A KR 20170042376 A KR20170042376 A KR 20170042376A
Authority
KR
South Korea
Prior art keywords
ser
gly
val
thr
leu
Prior art date
Application number
KR1020177009431A
Other languages
English (en)
Korean (ko)
Inventor
마크 스로스비
로버트 아르젠 크래머
코르넬리스 아드리안 데 크라위프
Original Assignee
크루셀 홀란드 비.브이.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 크루셀 홀란드 비.브이. filed Critical 크루셀 홀란드 비.브이.
Priority claimed from PCT/EP2007/055535 external-priority patent/WO2007141278A2/en
Publication of KR20170042376A publication Critical patent/KR20170042376A/ko

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/116—Polyvalent bacterial antigens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/12—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria
    • C07K16/1203—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria
    • C07K16/1228—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from bacteria from Gram-negative bacteria from Enterobacteriaceae (F), e.g. Citrobacter, Serratia, Proteus, Providencia, Morganella, Yersinia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
KR1020177009431A 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도 KR20170042376A (ko)

Applications Claiming Priority (11)

Application Number Priority Date Filing Date Title
US81154206P 2006-06-06 2006-06-06
EP06115013.2 2006-06-06
US60/811,542 2006-06-06
EP06115013 2006-06-06
EP06116719.3 2006-07-06
EP06116719 2006-07-06
EP06121258 2006-09-26
EP06121258.5 2006-09-26
EP07103587 2007-03-06
EP07103587.7 2007-03-06
PCT/EP2007/055535 WO2007141278A2 (en) 2006-06-06 2007-06-05 Human binding molecules having killing activity against enterococci and staphylococcus aureus and uses thereof

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
KR1020157035897A Division KR20160003317A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Related Child Applications (1)

Application Number Title Priority Date Filing Date
KR1020187009434A Division KR20180072676A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Publications (1)

Publication Number Publication Date
KR20170042376A true KR20170042376A (ko) 2017-04-18

Family

ID=45220170

Family Applications (3)

Application Number Title Priority Date Filing Date
KR1020187009434A KR20180072676A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도
KR1020177009431A KR20170042376A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도
KR1020157035897A KR20160003317A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Family Applications Before (1)

Application Number Title Priority Date Filing Date
KR1020187009434A KR20180072676A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Family Applications After (1)

Application Number Title Priority Date Filing Date
KR1020157035897A KR20160003317A (ko) 2006-06-06 2007-06-05 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도

Country Status (5)

Country Link
KR (3) KR20180072676A (ru)
CN (1) CN102731651B (ru)
CA (1) CA2891316C (ru)
EA (1) EA021767B1 (ru)
NZ (3) NZ606828A (ru)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10738342B2 (en) * 2018-08-30 2020-08-11 Urinary Technologies, Inc. System for microbial species detection, quantification and antibiotic susceptibility identification
CN113493510A (zh) * 2021-07-07 2021-10-12 上海交通大学 一种牛源抗金黄色葡萄球菌LukD毒力因子的单链抗体及其制备和应用
CN114196586B (zh) * 2021-12-20 2023-04-11 郑州大学 一株蒙氏肠球菌及其在发酵中草药中的应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6610293B1 (en) * 1997-06-16 2003-08-26 The Henry M. Jackson Foundation For The Advancement Of Military Medicine Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria
US6908994B1 (en) * 1999-05-10 2005-06-21 The Texas A&M University System Collagen-binding proteins from enterococcal bacteria
JP2005524624A (ja) * 2001-12-21 2005-08-18 バイオシネクサス インコーポレーテッド グラム陽性細菌のペプチドグリカンに対する多機能性モノクローナル抗体
JP2006502968A (ja) * 2002-02-21 2006-01-26 ユニヴエルシタ デリ スツディ ディ パヴィア 細菌性コラーゲン結合タンパク質に対して交差反応性のモノクロナール抗体

Also Published As

Publication number Publication date
CA2891316C (en) 2020-07-21
KR20180072676A (ko) 2018-06-29
EA021767B1 (ru) 2015-08-31
CN102731651B (zh) 2015-02-04
KR20160003317A (ko) 2016-01-08
EA201200182A1 (ru) 2012-06-29
NZ606828A (en) 2014-08-29
NZ594945A (en) 2013-03-28
NZ572775A (en) 2011-09-30
CA2891316A1 (en) 2007-12-13
CN102731651A (zh) 2012-10-17

Similar Documents

Publication Publication Date Title
CN101460518B (zh) 针对肠球菌和金黄色葡萄球菌具有杀伤活性的人结合分子及其应用
DK2027155T3 (en) HUMAN BINDING MOLECULES with killer activity against staphylococci and uses thereof
KR101485197B1 (ko) 인플루엔자 바이러스 ｈ5ｎ1을 중화시킬 수 있는 인간 결합분자 및 그것의 용도
KR101941724B1 (ko) 계통발생군 1과 계통발생군 2의 인플루엔자 a형 바이러스 및 인플루엔자 b형 바이러스를 중화시킬 수 있는 인간 결합분자
JP5813629B2 (ja) インフルエンザウイルスｈ３ｎ２を中和可能なヒト抗体及び／または抗原結合フラグメントおよびその使用
AU2006245734C1 (en) Host cell specific binding molecules capable of neutralizing viruses and uses thereof
CN101541832B (zh) 能中和流感病毒h5n1的人结合分子及其应用
AU2006290736A1 (en) Method for preparing immunoglobulin libraries
KR20170042376A (ko) 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도
KR20140095558A (ko) 장내구균에 대한 사멸활성을 갖는 인간결합분자 및 그것의 용도
NZ618530B2 (en) Human binding molecules capable of neutralizing influenza a viruses of phylogenetic group 1 and phylogenetic group 2 and influenza b viruses

Legal Events

Date Code Title Description
A107 Divisional application of patent
A201 Request for examination
E902 Notification of reason for refusal
E601 Decision to refuse application
J501 Disposition of invalidation of trial